Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species

Am J Physiol Cell Physiol. 2011 Sep;301(3):C695-704. doi: 10.1152/ajpcell.00322.2010. Epub 2011 Jun 8.

Abstract

Endothelial migration is a crucial aspect of a variety of physiologic and pathologic conditions including atherosclerosis and vascular repair. Reactive oxygen species (ROS) function as second messengers during endothelial migration. Multiple intracellular sources of ROS are regulated by cellular context, external stimulus, and the microenvironment. However, the predominant source of ROS during endothelial cell (EC) migration and the mechanisms by which ROS regulate cell migration are incompletely understood. In this study, we tested the hypothesis that mitochondria-derived ROS (mtROS) regulate EC migration. In cultured human umbilical vein endothelial cells, VEGF increased mitochondrial metabolism, promoted mtROS production, and induced cell migration. Either the targeted mitochondrial delivery of the antioxidant, vitamin E (Mito-Vit-E), or the depletion of mitochondrial DNA abrogated VEGF-mediated mtROS production. Overexpression of mitochondrial catalase also inhibited VEGF-induced mitochondrial metabolism, Rac activation, and cell migration. Furthermore, these interventions suppressed VEGF-stimulated EC migration and blocked Rac1 activation in endothelial cells. Constitutively active Rac1 reversed Mito-Vit-E-induced inhibition of EC migration. Mito-Vit-E also attenuated carotid artery reendothelialization in vivo. These results provide strong evidence that mtROS regulate EC migration through Rac-1.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Carotid Artery Injuries / pathology
  • Catalase / genetics
  • Catalase / metabolism
  • Cell Line
  • Cell Movement / drug effects
  • Cell Movement / physiology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cyclooxygenase 2 / metabolism
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • DNA Polymerase gamma
  • DNA-Directed DNA Polymerase / genetics
  • DNA-Directed DNA Polymerase / metabolism
  • Electron Transport Complex IV / metabolism
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / injuries
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Human Umbilical Vein Endothelial Cells / cytology*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Hydrogen Peroxide / antagonists & inhibitors
  • Hydrogen Peroxide / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA, Small Interfering / genetics
  • Reactive Oxygen Species / metabolism*
  • Regeneration / drug effects
  • Regeneration / physiology
  • Superoxides / metabolism
  • Transduction, Genetic
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Vitamin E / pharmacology
  • p21-Activated Kinases / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism
  • rac1 GTP-Binding Protein / genetics
  • rac1 GTP-Binding Protein / metabolism
  • von Willebrand Factor / metabolism

Substances

  • RAC1 protein, human
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • von Willebrand Factor
  • Superoxides
  • Vitamin E
  • Hydrogen Peroxide
  • Catalase
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Electron Transport Complex IV
  • Proto-Oncogene Proteins c-akt
  • p21-Activated Kinases
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • DNA Polymerase gamma
  • DNA-Directed DNA Polymerase
  • POLG protein, human
  • rac1 GTP-Binding Protein